Avadel Pharmaceuticals PLC (NASDAQ:AVDL)
| 10.74 Delayed Data As of Sep 27 |  -0.43 / -3.85%Today’s Change | 4.70 Today|||52-Week Range 16.85 | +50.00% Year-to-Date |
Latest AVDL News | Press Releases
| Avadel Pharmaceuticals PLC (AVDL): Is It Really Priced Right? An In-depth Exploration Sep 26 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 11.17 |
| Today’s open | 11.17 |
| Day’s range | 10.65 - 11.30 |
| Volume | 19,098 |
| Average volume (3 months) | 705,829 |
| Market cap | $1.0B |
Data as of 3:59pm ET, 09/27/2023
Growth & Valuation
| Earnings growth (last year) | -73.15% |
| Earnings growth (this year) | +44.81% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
Data as of 3:59pm ET, 09/27/2023
Financials
| Next reporting date | November 6, 2023 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$137.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
